Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting von EBERHARD, David A, GIACCONE, Giuseppe, JOHNSON, Bruce E

Volltext

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone a... von EBERHARD, David A, JOHNSON, Bruce E, KLEIN, Pam, MILLER, Vincent A, OSTLAND, Michael A, RAMIES, David A, SEBISANOVIC, Dragan, STINSON, Jeremy A, ZHANG, Yu R, SESHAGIRI, Somasekar, HILLAN, Kenneth J, AMLER, Lukas C, GODDARD, Audrey D, HELDENS, Sherry L, HERBST, Roy S, INCE, William L, JÄNNE, Pasi A, JANUARIO, Thomas, JOHNSON, David H

Volltext

Enhancing Next‐Generation Sequencing‐Guided Cancer Care Through Cognitive Computing von Patel, Nirali M., Michelini, Vanessa V., Snell, Jeff M., Balu, Saianand, Hoyle, Alan P., Parker, Joel S., Hayward, Michele C., Eberhard, David A., Salazar, Ashley H., McNeillie, Patrick, Xu, Jia, Huettner, Claudia S., Koyama, Takahiko, Utro, Filippo, Rhrissorrakrai, Kahn, Norel, Raquel, Bilal, Erhan, Royyuru, Ajay, Parida, Laxmi, Earp, H. Shelton, Grilley‐Olson, Juneko E., Hayes, D. Neil, Harvey, Stephen J., Sharpless, Norman E., Kim, William Y.

Volltext

Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib von Haas-Kogan, Daphne A., Prados, Michael D., Tihan, Tarik, Eberhard, David A., Jelluma, Nannette, Arvold, Nils D., Baumber, Rachel, Lamborn, Kathleen R., Kapadia, Ami, Malec, Mary, Berger, Mitchel S., Stokoe, David

Volltext

Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients von Yauch, Robert L, Januario, Thomas, Eberhard, David A, Cavet, Guy, Zhu, Wenjing, Fu, Ling, Pham, Thinh Q, Soriano, Robert, Stinson, Jeremy, Seshagiri, Somasekar, Modrusan, Zora, Lin, Chin-Yu, O'Neill, Vincent, Amler, Lukas C

Volltext

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kina... von HERBST, Roy S, JOHNSON, David H, HONG, Waun K, TRAN, Hai, TSAO, Anne, DONG XIE, RAMIES, David A, MASS, Robert, SESHAGIRI, Somasekar, EBERHARD, David A, KELLEY, Sean K, SANDLER, Alan, MININBERG, Eric, CARBONE, David P, HENDERSON, Ted, KIM, Edward S, BLUMENSCHEIN, George JR, LEE, Jack J, LIU, Diane D, TRUONG, Mylene T

Volltext

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration von McShane, Lisa M, Cavenagh, Margaret M, Lively, Tracy G, Eberhard, David A, Bigbee, William L, Williams, P Mickey, Mesirov, Jill P, Polley, Mei-Yin C, Kim, Kelly Y, Tricoli, James V, Taylor, Jeremy M G, Shuman, Deborah J, Simon, Richard M, Doroshow, James H, Conley, Barbara A

Volltext

A Revised Earthquake Catalogue for South Iceland von Panzera, Francesco, Zechar, J. Douglas, Vogfjörd, Kristín S., Eberhard, David A. J.

Volltext

Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC von Zhao, Xiaobei, Wang, Anyou, Walter, Vonn, Patel, Nirali M, Eberhard, David A, Hayward, Michele C, Salazar, Ashley H, Jo, Heejoon, Soloway, Matthew G, Wilkerson, Matthew D, Parker, Joel S, Yin, Xiaoying, Zhang, Guosheng, Siegel, Marni B, Rosson, Gary B, Earp, 3rd, H Shelton, Sharpless, Norman E, Gulley, Margaret L, Weck, Karen E, Hayes, D Neil, Moschos, Stergios J

Volltext

Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors von Busch, Evan L, Don, Prabhani Kuruppumullage, Chu, Haitao, Richardson, David B, Keku, Temitope O, Eberhard, David A, Avery, Christy L, Sandler, Robert S

Volltext

A prospective earthquake forecast experiment in the western Pacific von Eberhard, David A. J., Zechar, J. Douglas, Wiemer, Stefan

Volltext

Diverse somatic mutation patterns and pathway alterations in human cancers von Li, Li, Waring, Paul, Stern, Howard M, Stokoe, David, Zheng, Jianbiao, Eberhard, David A, Chaudhuri, Subhra, Moorhead, Martin, Wang, Weiru, Yue, Peng, Modrusan, Zora, Pujara, Kanan, Faham, Malek, Davis, David P, Eigenbrot, Charles, Tomsho, Lynn P, Janakiraman, Vasantharajan, Stinson, Jeremy, Bourgon, Richard, Carlton, Victoria E. H, Jaiswal, Bijay S, Seshagiri, Somasekar, Kaminker, Joshua S, Schuster, Stephan C, Kan, Zhengyan, Peters, Brock A, Cordes, Shaun, Zhang, Zemin, de Sauvage, Frederic J, Bhatt, Deepali, Haverty, Peter M, Yuan, Wenlin

Volltext

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffus... von Czuczman, Myron S, Trněný, Marek, Davies, Andrew, Rule, Simon, Linton, Kim M, Wagner-Johnston, Nina, Gascoyne, Randy D, Slack, Graham W, Brousset, Pierre, Eberhard, David A, Hernandez-Ilizaliturri, Francisco J, Salles, Gilles, Witzig, Thomas E, Zinzani, Pier Luigi, Wright, George W, Staudt, Louis M, Yang, Yandan, Williams, P Mickey, Lih, Chih-Jian, Russo, Jacqueline, Thakurta, Anjan, Hagner, Patrick, Fustier, Pierre, Song, Dale, Lewis, Ian D

Volltext

Criteria for the use of omics-based predictors in clinical trials von McShane, Lisa M., Cavenagh, Margaret M., Lively, Tracy G., Eberhard, David A., Bigbee, William L., Williams, P. Mickey, Mesirov, Jill P., Polley, Mei-Yin C., Kim, Kelly Y., Tricoli, James V., Taylor, Jeremy M. G., Shuman, Deborah J., Simon, Richard M., Doroshow, James H., Conley, Barbara A.

Volltext

Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue von Potts, Steven J, Krueger, Joseph S, Landis, Nicholas D, Eberhard, David A, David Young, G, Schmechel, Steven C, Lange, Holger

Volltext

The molecular basis of breast cancer pathological phenotypes von Heng, Yujing J, Lester, Susan C, Tse, Gary MK, Factor, Rachel E, Allison, Kimberly H, Collins, Laura C, Chen, Yunn‐Yi, Jensen, Kristin C, Johnson, Nicole B, Jeong, Jong Cheol, Punjabi, Rahi, Shin, Sandra J, Singh, Kamaljeet, Krings, Gregor, Eberhard, David A, Tan, Puay Hoon, Korski, Konstanty, Waldman, Frederic M, Gutman, David A, Sanders, Melinda, Reis‐Filho, Jorge S, Flanagan, Sydney R, Gendoo, Deena MA, Chen, Gregory M, Haibe‐Kains, Benjamin, Ciriello, Giovanni, Hoadley, Katherine A, Perou, Charles M, Beck, Andrew H

Volltext

Control of the nuclear-cytoplasmic partitioning of annexin II by a nuclear export signal and by p11 binding von Eberhard, D A, Karns, L R, VandenBerg, S R, Creutz, C E

Volltext

Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development von Potts, Steven J, Eberhard, David A, Keith A. Wharton, Jr

Volltext

Evaluating markers of epithelial-mesenchymal transition to identify cancer patients at risk for metastatic disease von Busch, Evan L., Keku, Temitope O., Richardson, David B., Cohen, Stephanie M., Eberhard, David A., Avery, Christy L., Sandler, Robert S.

Volltext

Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma von Jeck, William R., Parker, Joel, Carson, Craig C., Shields, Janiel M., Sambade, Maria J., Peters, Eldon C., Burd, Christin E., Thomas, Nancy E., Chiang, Derek Y., Liu, Wenjin, Eberhard, David A., Ollila, David, Grilley-Olson, Juneko, Moschos, Stergios, Neil Hayes, D., Sharpless, Norman E.

Volltext